Pancreatic Cancer Research

ResearcherVita-Salute San Raffaele UniversityActive in the last 2 years

Catia Carconi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3374-4220; OpenAlex author ID A5049308798. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
54
Papers, trials and grants by year

2024: 3 papers · 2025: none · 2026: 5 papers

Papers 8

  1. Pancreatic adenocarcinoma nutritional-clinical index (PANCIN): A novel prognostic tool in advanced pancreatic cancer. Co-author DOI 10.1016/j.dld.2026.02.015↗
  2. A robust biomarker combining radiomic and CA19.9 information to predict distant relapse-free survival after radiochemotherapy in pancreatic cancer. Co-author DOI 10.1016/j.dld.2026.09.026↗
  3. Short-term versus long-course neoadjuvant chemotherapy for resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results f… Co-author DOI 10.1016/j.eclinm.2026.104190↗
  4. Impact of center-level protocol adherence on neoadjuvant treatment outcome in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejca.2026.117033↗
  5. Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the … Co-author DOI 10.1016/s0140-6736(25)01685-x↗
  6. Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients. First author DOI 10.1016/j.ejca.2024.114226↗
  7. A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants. Co-author DOI 10.1016/j.pan.2024.09.006↗
  8. Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease. Co-author DOI 10.1053/j.seminoncol.2024.04.001↗

Closest collaborators

The 25 strongest of 54 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Giulia Orsi · 8 shared papers, 2024–2026 · strength 1.64
  2. Michele Reni · 8 shared papers, 2024–2026 · strength 1.64
  3. Marina Macchini · 7 shared papers, 2024–2026 · strength 1.43
  4. Massimo Falconi · 6 shared papers, 2024–2026 · strength 1.24
  5. Diego Palumbo · 3 shared papers, 2026 · strength 0.67
  6. Giuseppe Malleo · 3 shared papers, 2026 · strength 0.65
  7. Letizia Procaccio · 3 shared papers, 2026 · strength 0.65
  8. Mariacristina Di Marco · 3 shared papers, 2026 · strength 0.65
  9. Ilario Giovanni Rapposelli · 3 shared papers, 2026 · strength 0.65
  10. Michèle Milella · 3 shared papers, 2026 · strength 0.65
  11. Sara Lonardi · 3 shared papers, 2024–2026 · strength 0.61
  12. Mario Scartozzi · 3 shared papers, 2024–2026 · strength 0.60
  13. Gabriele Capurso · 3 shared papers, 2024–2026 · strength 0.60
  14. Nicolò Pecorelli · 2 shared papers, 2026 · strength 0.46
  15. Claudio Fiorino · 2 shared papers, 2026 · strength 0.45
  16. M. De Vincenzi · 2 shared papers, 2026 · strength 0.45
  17. Giovanni Guarneri · 2 shared papers, 2026 · strength 0.45
  18. Silvia Bozzarelli · 2 shared papers, 2026 · strength 0.43
  19. Giuseppe Vanella · 1 shared paper, 2026 · strength 0.23
  20. Stefano Partelli · 1 shared paper, 2026 · strength 0.22
  21. Andrea Pretta · 1 shared paper, 2026 · strength 0.22
  22. Stefano Crippa · 1 shared paper, 2026 · strength 0.22
  23. Martina Mori · 1 shared paper, 2026 · strength 0.22
  24. Nadia Gisella Di Muzio · 1 shared paper, 2026 · strength 0.22
  25. Paolo Passoni · 1 shared paper, 2026 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.